ALGS - Aligos Therapeutics, Inc.
6.98
0.320 4.585%
Share volume: 87,271
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$6.66
0.32
0.05%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-07-2024 | 08-06-2024 | 11-06-2024 | 03-10-2025 | 05-06-2025 | 11-06-2025 | 03-05-2026 | |
| Cash flow financing | -19.000 K | 281.000 K | -4.000 K | 97.000 K | 101.742 M | -53.000 K | 123.000 K | |
| Other financing cash flows | -19.000 K | -16.000 K | -5.000 K | -43.000 K | 0.000 | -10.000 K | -3.000 K | |
| Cash flow | -111.407 M | 20.781 M | -9.707 M | 1.666 M | 36.766 M | 23.285 M | -23.643 M | |
| Net income | -34.863 M | 5.061 M | -19.259 M | -82.150 M | 43.088 M | -31.537 M | -19.881 M | |
| Depreciation | 282.000 K | 256.000 K | 248.000 K | 241.000 K | 194.000 K | 220.000 K | 257.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -88.642 M | 39.993 M | 10.398 M | 19.972 M | -44.067 M | 47.683 M | -2.021 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 69.000 K | 7.000 K | 26.000 K | 28.000 K | 43.000 K | 193.000 K | 92.000 K | |
| Cash Change | -111.407 M | 20.781 M | -9.707 M | 1.666 M | 36.766 M | 23.285 M | -23.643 M |